Breakthrough bacteremia and septic shock due to Streptococcus anginosus resistant to daptomycin in a patient receiving daptomycin therapy

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 7, 2011, Pages 3639-3640

  Palacio, Federico ^a   Lewis II, James S ^b   Sadkowski, Lee ^c   Echevarria, Kelly ^c   Jorgensen, James H ^d  

^a University of Texas Health Science Center   (United States)

^b UNIVERSITY HEALTH SYSTEM   (United States)

^c SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; CLINDAMYCIN; CREATININE; DAPTOMYCIN; ERYTHROMYCIN; LEVOFLOXACIN; MEROPENEM; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; TETRACYCLINE; VANCOMYCIN;

ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTEREMIA; BLOOD CULTURE; CASE REPORT; CHRONIC KIDNEY DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETES MELLITUS; HUMAN; HYPERTENSION; INTENSIVE CARE UNIT; LETTER; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; NEUROGENIC BLADDER; PARAPLEGIA; PRIORITY JOURNAL; SEPTIC SHOCK; STREPTOCOCCUS ANGINOSUS; STREPTOCOCCUS INFECTION; TREATMENT DURATION;

ANTI-BACTERIAL AGENTS; BACTEREMIA; DAPTOMYCIN; HUMANS; MALE; MIDDLE AGED; SHOCK, SEPTIC; STREPTOCOCCUS ANGINOSUS;

EID: 79959195186     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00231-11     Document Type: Letter

References (14)

1. Anderson, E. T., L. S. Young, and W. L. Hewitt. 1976. Simultaneous antibiotic levels in "breakthrough" gram-negative rod bacteremia. Am. J. Med. 61:493-497.
2. Calza, L., R. Manfredi, E. Briganti, L. Attard, and F. Chiodo. 2001. Iliac osteomyelitis and gluteal muscle abscess caused by Streptococcus intermedius. J. Med. Microbiol. 50:480-482.
3. Carpenter, C. F., and F. C. Henry. 2004. Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens. Clin. Infect. Dis. 38:994-1000.
4. Casariego, E., et al. 1996. Prospective study of Streptococcus milleri bacteremia. Eur. J. Clin. Microbiol. 15:194-200.
5. Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing; 21st informational supplement M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA.
6. EUCAST. 2011. Breakpoint tables for interpretation of MICs and zone diameters. Version 1.3. European Committee on Antimicrobial Susceptibility Testing, Vaxjo, Sweden. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST- files/Disk-test-documents/EUCAST-breakpoints-v1.3-pdf.pdf.
7. Lewis, J. S., et al. 2005. Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy. Antimicrob. Agents Chemother. 49:1664-1665.
8. Mangili, A., I. Bica, D. R. Snydman, and D. H. Hamer. 2005. Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia. Clin. Infect. Dis. 40:1058-1060.
9. Molina, J. M., et al. 1991. Clinical and bacterial features of infections caused by Streptococcus milleri. Scand. J. Infect. Dis. 23:659-666.
10. Ortel, T. L., J. Kallianos, and H. A. Gallis. 1990. Group C streptococcal arthritis: case report and review. Rev. Infect. Dis. 12:829-837.
11. Ripley, R. T., et al. 2006. Streptococcus milleri infections of the pleural space: operative management predominates. Am. J. Surg. 192:817-821.
12. Shishido, H., K. Watanabe, K. Matsumoto, K. Murakami, and K. Sato. 1997. Primary purulent mediastinitis due to Streptococcus milleri. Respiration 64:313-315. (Pubitemid 27277851)
13. Spellerberg, B., and C. Brandt. 2007. Streptococcus, p. 412-429. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. Landry, and M. Pfaller (ed.), Manual of clinical microbiology, 9th ed. American Society for Microbiology, Washington, DC.
14. Whiley, R. A., and D. Beighton. 1991. Emended descriptions and recognition of Streptococcus constellatus, Streptococcus intermedius, and Streptococcus anginosus as distinct species. Int. J. Syst. Bacteriol. 41:1-5.